Skip to main content

APPLICATION

A better system for
internal engagement and training.

Need to collaborate with colleagues? Use Within3 to engage team members spread across time zones, countries, or continents. Round-the-clock accessibility means you never interfere with anyone’s work schedule, and a structured platform sharpens your team’s focus for better engagement and training.

STRUCTURED PLATFORM

Deadline-driven
engagement

Focus your training and engagement with a
structured workflow that features
automatic reminders and in-system
deadlines.

TRAINING AND KNOWLEDGE ASSESSMENT

On-demand training

Allow individuals to access training
resources on their own schedule and ensure
that training is complete and successful.

ASYNCHRONOUS DISCUSSIONS

24/7 Environment

Open for days or weeks and accessible on
any device, so busy schedules and time
zone differences are no longer obstacles for
engagement.

CASE STUDY

Learn how a medical
affairs team conducted
deep-dive training for a
group of MSLs located
across the US.

Read the Case Study

Business Results

Total participation

Our structured, deadline-driven
platform delivers active
engagement—from every
participant.

Less wasted time

Training and engagement takes
less effort, so you can get back to
the real work.

Stronger Teams

Have more productive
conversations with your team to
better understand their needs-
and the needs of your customers.

orphan drug challenges

Within3 in MedCity News

September 19, 2023 | News | No Comments
Advanced technology can help the pharmaceutical industry work through the inherent challenges of orphan drug development.
AI in pharma news

Within3 in industry tech news

September 14, 2023 | News | No Comments
Innovative applications for AI are making news in the pharma industry. Here's an update on the latest.
insights innovation for medical affairs

CEO Lance Hill in Gold Magazine

August 22, 2023 | News | No Comments
Medical affairs organizations are seeking effective applications for advanced technologies.

More insights, direct to your inbox.

Get our newsletter.